Global Pharmacovigilance Outsourcing Market

Pharmacovigilance Outsourcing Comprehensive Study by Type (Drug safety surveillance., Drug abuse and adverse effects monitoring., Safety monitoring of new products.), Application (Detection,, Assessment,, Understanding, Prevention of adverse effects, Medicine/vaccine related), Services (Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)), Service Providers (Contract Research Organizations, Business Processing Outsourcing), Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV) Players and Region - Global Market Outlook to 2028

Pharmacovigilance Outsourcing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
A pharmacovigilance outsourcing enables the clients to interact with one service provider for all the Pharmacovigilance (PV) and regulatory requirements, which translates into a cost and time-effective strategy. Pharmacovigilance outsourcing (PVO) transfers the execution of drug safety functions and processes to a third-party provider. These include primary PV activities like case processing, as well as governance activities like compliance management. These services are majorly outsourced by small and mid-size pharmaceutical and biotechnology companies with an aim to save costs and focus on the company’s core activities.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Market Drivers
  • Cost-effective Pharmacovigilance Services in Developing Countries
  • High Profile Drug Recalls due to Safety Concerns

Market Trend
  • Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease

Restraints
  • The Risk associated with Data Security

Opportunities
High Potential in Developing Countries and Increasing Adverse Drug Reactions Associated with Pharmaceutical Products Used in the Prevention and Treatment of Various Diseases

Pharmacovigilance Outsourcing Market Segmentation:
ScopeSub-Segments
Application / End Userdetection,, assessment,, understanding, prevention of adverse effects and medicine/vaccine related
TypeDrug safety surveillance., Drug abuse and adverse effects monitoring. and Safety monitoring of new products.
ServicesPre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)
Service Providers Contract Research Organizations,Business Processing Outsourcing
Clinical Trial PhasePre-Clinical,Phase I,Phase II,Phase III,Phase IV


Players Covered in the Study are:
Accenture plc (Ireland), Clinquest Group B.V (Netherlands), Cognizant (United States), Laboratory Corporation of America Holdings (United States), IBM (United States), ArisGlobal LLC (United States), ITClinical (Portugal), Foresight Group International AG (Switzerland) and Take Solutions Ltd. (India)

The Global Pharmacovigilance Outsourcing market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.

Industry Insights:
In Dec. , 2023 – Accenture (NYSE: ACN) has signed an agreement to acquire Customer Management IT and SirfinPA, a pair of jointly-owned Italian technology consultancies supporting the public sector and specializing in justice and public safety. The acquisition aligns with Accenture’s focus on helping Italian public service organizations build their digital core and deliver enhanced services to the citizens they serve.
In February 2022, Cognizant entered into a partnership with Medable Inc. to jointly deliver clinical research solutions based on Medable's software-as-a-service platform for decentralized clinical trials. Source:


Key Target Audience
Pharmacovigilance Outsourcing Providers, Potential Investors, Research and Development Firm and End-User Industries

What can be explored with Pharmacovigilance Outsourcing study:
• Where Pharmacovigilance Outsourcing industry stands in scaling its end use implementations
• What concrete benefits would result from scaled initiatives by Players
• Where Players should focus their investments cycle
• Key success factors and recommendations for upscaling future growth.
• Target Market / Country and Key Business Segments

Available Customization:
List of players that can be included in the study on immediate basis are Bioclinica (United States) and Parexel International (United States).


Report Objectives / Segmentation Covered

By Type
  • Drug safety surveillance.
  • Drug abuse and adverse effects monitoring.
  • Safety monitoring of new products.
By Application
  • detection,
  • assessment,
  • understanding
  • prevention of adverse effects
  • medicine/vaccine related
By Services
  • Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)

By Service Providers
  • Contract Research Organizations
  • Business Processing Outsourcing

By Clinical Trial Phase
  • Pre-Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Cost-effective Pharmacovigilance Services in Developing Countries
      • 3.2.2. High Profile Drug Recalls due to Safety Concerns
    • 3.3. Market Challenges
      • 3.3.1. The Dearth of Skilled Personnel.
    • 3.4. Market Trends
      • 3.4.1. Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmacovigilance Outsourcing, by Type, Application, Services, Service Providers , Clinical Trial Phase and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharmacovigilance Outsourcing (Value)
      • 5.2.1. Global Pharmacovigilance Outsourcing by: Type (Value)
        • 5.2.1.1. Drug safety surveillance.
        • 5.2.1.2. Drug abuse and adverse effects monitoring.
        • 5.2.1.3. Safety monitoring of new products.
      • 5.2.2. Global Pharmacovigilance Outsourcing by: Application (Value)
        • 5.2.2.1. Detection,
        • 5.2.2.2. Assessment,
        • 5.2.2.3. Understanding
        • 5.2.2.4. Prevention of adverse effects
        • 5.2.2.5. Medicine/vaccine related
      • 5.2.3. Global Pharmacovigilance Outsourcing by: Services (Value)
        • 5.2.3.1. Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)
      • 5.2.4. Global Pharmacovigilance Outsourcing by: Clinical Trial Phase (Value)
        • 5.2.4.1. Pre-Clinical
        • 5.2.4.2. Phase I
        • 5.2.4.3. Phase II
        • 5.2.4.4. Phase III
        • 5.2.4.5. Phase IV
      • 5.2.5. Global Pharmacovigilance Outsourcing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharmacovigilance Outsourcing (Price)
      • 5.3.1. Global Pharmacovigilance Outsourcing by: Type (Price)
  • 6. Pharmacovigilance Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Accenture plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Clinquest Group B.V (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cognizant (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Laboratory Corporation of America Holdings (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. IBM (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ArisGlobal LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ITClinical (Portugal)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Foresight Group International AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Take Solutions Ltd. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Pharmacovigilance Outsourcing Sale, by Type, Application, Services, Service Providers , Clinical Trial Phase and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharmacovigilance Outsourcing (Value)
      • 7.2.1. Global Pharmacovigilance Outsourcing by: Type (Value)
        • 7.2.1.1. Drug safety surveillance.
        • 7.2.1.2. Drug abuse and adverse effects monitoring.
        • 7.2.1.3. Safety monitoring of new products.
      • 7.2.2. Global Pharmacovigilance Outsourcing by: Application (Value)
        • 7.2.2.1. Detection,
        • 7.2.2.2. Assessment,
        • 7.2.2.3. Understanding
        • 7.2.2.4. Prevention of adverse effects
        • 7.2.2.5. Medicine/vaccine related
      • 7.2.3. Global Pharmacovigilance Outsourcing by: Services (Value)
        • 7.2.3.1. Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services)
      • 7.2.4. Global Pharmacovigilance Outsourcing by: Clinical Trial Phase (Value)
        • 7.2.4.1. Pre-Clinical
        • 7.2.4.2. Phase I
        • 7.2.4.3. Phase II
        • 7.2.4.4. Phase III
        • 7.2.4.5. Phase IV
      • 7.2.5. Global Pharmacovigilance Outsourcing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharmacovigilance Outsourcing (Price)
      • 7.3.1. Global Pharmacovigilance Outsourcing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmacovigilance Outsourcing: by Type(USD Million)
  • Table 2. Pharmacovigilance Outsourcing Drug safety surveillance. , by Region USD Million (2017-2022)
  • Table 3. Pharmacovigilance Outsourcing Drug abuse and adverse effects monitoring. , by Region USD Million (2017-2022)
  • Table 4. Pharmacovigilance Outsourcing Safety monitoring of new products. , by Region USD Million (2017-2022)
  • Table 5. Pharmacovigilance Outsourcing: by Application(USD Million)
  • Table 6. Pharmacovigilance Outsourcing Detection, , by Region USD Million (2017-2022)
  • Table 7. Pharmacovigilance Outsourcing Assessment, , by Region USD Million (2017-2022)
  • Table 8. Pharmacovigilance Outsourcing Understanding , by Region USD Million (2017-2022)
  • Table 9. Pharmacovigilance Outsourcing Prevention of adverse effects , by Region USD Million (2017-2022)
  • Table 10. Pharmacovigilance Outsourcing Medicine/vaccine related , by Region USD Million (2017-2022)
  • Table 11. Pharmacovigilance Outsourcing: by Services(USD Million)
  • Table 12. Pharmacovigilance Outsourcing Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services) , by Region USD Million (2017-2022)
  • Table 13. Pharmacovigilance Outsourcing: by Clinical Trial Phase(USD Million)
  • Table 14. Pharmacovigilance Outsourcing Pre-Clinical , by Region USD Million (2017-2022)
  • Table 15. Pharmacovigilance Outsourcing Phase I , by Region USD Million (2017-2022)
  • Table 16. Pharmacovigilance Outsourcing Phase II , by Region USD Million (2017-2022)
  • Table 17. Pharmacovigilance Outsourcing Phase III , by Region USD Million (2017-2022)
  • Table 18. Pharmacovigilance Outsourcing Phase IV , by Region USD Million (2017-2022)
  • Table 19. South America Pharmacovigilance Outsourcing, by Country USD Million (2017-2022)
  • Table 20. South America Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 21. South America Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 22. South America Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 23. South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 24. South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 25. Brazil Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 26. Brazil Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 27. Brazil Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 28. Brazil Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 29. Brazil Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 30. Argentina Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 31. Argentina Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 32. Argentina Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 33. Argentina Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 34. Argentina Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 35. Rest of South America Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 36. Rest of South America Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 37. Rest of South America Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 38. Rest of South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 39. Rest of South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 40. Asia Pacific Pharmacovigilance Outsourcing, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 42. Asia Pacific Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 43. Asia Pacific Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 44. Asia Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 45. Asia Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 46. China Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 47. China Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 48. China Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 49. China Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 50. China Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 51. Japan Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 52. Japan Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 53. Japan Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 54. Japan Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 55. Japan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 56. India Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 57. India Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 58. India Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 59. India Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 60. India Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 61. South Korea Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 62. South Korea Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 63. South Korea Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 64. South Korea Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 65. South Korea Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 66. Taiwan Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 67. Taiwan Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 68. Taiwan Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 69. Taiwan Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 70. Taiwan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 71. Australia Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 72. Australia Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 73. Australia Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 74. Australia Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 75. Australia Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 81. Europe Pharmacovigilance Outsourcing, by Country USD Million (2017-2022)
  • Table 82. Europe Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 83. Europe Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 84. Europe Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 85. Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 86. Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 87. Germany Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 88. Germany Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 89. Germany Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 90. Germany Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 91. Germany Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 92. France Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 93. France Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 94. France Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 95. France Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 96. France Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 97. Italy Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 98. Italy Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 99. Italy Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 100. Italy Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 101. Italy Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 102. United Kingdom Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 103. United Kingdom Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 104. United Kingdom Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 105. United Kingdom Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 106. United Kingdom Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 107. Netherlands Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 108. Netherlands Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 109. Netherlands Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 110. Netherlands Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 111. Netherlands Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 112. Rest of Europe Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 113. Rest of Europe Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 114. Rest of Europe Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 115. Rest of Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 116. Rest of Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 117. MEA Pharmacovigilance Outsourcing, by Country USD Million (2017-2022)
  • Table 118. MEA Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 119. MEA Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 120. MEA Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 121. MEA Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 122. MEA Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 123. Middle East Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 124. Middle East Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 125. Middle East Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 126. Middle East Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 127. Middle East Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 128. Africa Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 129. Africa Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 130. Africa Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 131. Africa Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 132. Africa Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 133. North America Pharmacovigilance Outsourcing, by Country USD Million (2017-2022)
  • Table 134. North America Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 135. North America Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 136. North America Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 137. North America Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 138. North America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 139. United States Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 140. United States Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 141. United States Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 142. United States Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 143. United States Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 144. Canada Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 145. Canada Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 146. Canada Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 147. Canada Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 148. Canada Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 149. Mexico Pharmacovigilance Outsourcing, by Type USD Million (2017-2022)
  • Table 150. Mexico Pharmacovigilance Outsourcing, by Application USD Million (2017-2022)
  • Table 151. Mexico Pharmacovigilance Outsourcing, by Services USD Million (2017-2022)
  • Table 152. Mexico Pharmacovigilance Outsourcing, by Service Providers USD Million (2017-2022)
  • Table 153. Mexico Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2017-2022)
  • Table 154. Pharmacovigilance Outsourcing: by Type(USD/Units)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Pharmacovigilance Outsourcing: by Type(USD Million)
  • Table 165. Pharmacovigilance Outsourcing Drug safety surveillance. , by Region USD Million (2023-2028)
  • Table 166. Pharmacovigilance Outsourcing Drug abuse and adverse effects monitoring. , by Region USD Million (2023-2028)
  • Table 167. Pharmacovigilance Outsourcing Safety monitoring of new products. , by Region USD Million (2023-2028)
  • Table 168. Pharmacovigilance Outsourcing: by Application(USD Million)
  • Table 169. Pharmacovigilance Outsourcing Detection, , by Region USD Million (2023-2028)
  • Table 170. Pharmacovigilance Outsourcing Assessment, , by Region USD Million (2023-2028)
  • Table 171. Pharmacovigilance Outsourcing Understanding , by Region USD Million (2023-2028)
  • Table 172. Pharmacovigilance Outsourcing Prevention of adverse effects , by Region USD Million (2023-2028)
  • Table 173. Pharmacovigilance Outsourcing Medicine/vaccine related , by Region USD Million (2023-2028)
  • Table 174. Pharmacovigilance Outsourcing: by Services(USD Million)
  • Table 175. Pharmacovigilance Outsourcing Pre-marketing Pharmacovigilance Services (Clinical Pharmacovigilance Services, Case-Processing Services, Safety Data Management Services, Medical Review) Post-marketing Pharmacovigilance Services (Pharmacovigilance Knowledge Process Outsourcing Services, IT Solutions, and Services) , by Region USD Million (2023-2028)
  • Table 176. Pharmacovigilance Outsourcing: by Clinical Trial Phase(USD Million)
  • Table 177. Pharmacovigilance Outsourcing Pre-Clinical , by Region USD Million (2023-2028)
  • Table 178. Pharmacovigilance Outsourcing Phase I , by Region USD Million (2023-2028)
  • Table 179. Pharmacovigilance Outsourcing Phase II , by Region USD Million (2023-2028)
  • Table 180. Pharmacovigilance Outsourcing Phase III , by Region USD Million (2023-2028)
  • Table 181. Pharmacovigilance Outsourcing Phase IV , by Region USD Million (2023-2028)
  • Table 182. South America Pharmacovigilance Outsourcing, by Country USD Million (2023-2028)
  • Table 183. South America Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 184. South America Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 185. South America Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 186. South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 187. South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 188. Brazil Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 189. Brazil Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 190. Brazil Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 191. Brazil Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 192. Brazil Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 193. Argentina Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 194. Argentina Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 195. Argentina Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 196. Argentina Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 197. Argentina Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 198. Rest of South America Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 199. Rest of South America Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 200. Rest of South America Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 201. Rest of South America Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 202. Rest of South America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 203. Asia Pacific Pharmacovigilance Outsourcing, by Country USD Million (2023-2028)
  • Table 204. Asia Pacific Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 205. Asia Pacific Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 206. Asia Pacific Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 207. Asia Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 208. Asia Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 209. China Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 210. China Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 211. China Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 212. China Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 213. China Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 214. Japan Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 215. Japan Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 216. Japan Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 217. Japan Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 218. Japan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 219. India Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 220. India Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 221. India Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 222. India Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 223. India Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 224. South Korea Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 225. South Korea Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 226. South Korea Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 227. South Korea Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 228. South Korea Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 229. Taiwan Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 230. Taiwan Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 231. Taiwan Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 232. Taiwan Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 233. Taiwan Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 234. Australia Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 235. Australia Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 236. Australia Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 237. Australia Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 238. Australia Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 239. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 240. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 241. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 242. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 243. Rest of Asia-Pacific Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 244. Europe Pharmacovigilance Outsourcing, by Country USD Million (2023-2028)
  • Table 245. Europe Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 246. Europe Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 247. Europe Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 248. Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 249. Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 250. Germany Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 251. Germany Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 252. Germany Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 253. Germany Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 254. Germany Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 255. France Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 256. France Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 257. France Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 258. France Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 259. France Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 260. Italy Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 261. Italy Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 262. Italy Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 263. Italy Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 264. Italy Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 265. United Kingdom Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 266. United Kingdom Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 267. United Kingdom Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 268. United Kingdom Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 269. United Kingdom Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 270. Netherlands Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 271. Netherlands Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 272. Netherlands Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 273. Netherlands Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 274. Netherlands Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 275. Rest of Europe Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 276. Rest of Europe Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 277. Rest of Europe Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 278. Rest of Europe Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 279. Rest of Europe Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 280. MEA Pharmacovigilance Outsourcing, by Country USD Million (2023-2028)
  • Table 281. MEA Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 282. MEA Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 283. MEA Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 284. MEA Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 285. MEA Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 286. Middle East Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 287. Middle East Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 288. Middle East Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 289. Middle East Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 290. Middle East Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 291. Africa Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 292. Africa Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 293. Africa Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 294. Africa Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 295. Africa Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 296. North America Pharmacovigilance Outsourcing, by Country USD Million (2023-2028)
  • Table 297. North America Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 298. North America Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 299. North America Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 300. North America Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 301. North America Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 302. United States Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 303. United States Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 304. United States Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 305. United States Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 306. United States Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 307. Canada Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 308. Canada Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 309. Canada Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 310. Canada Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 311. Canada Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 312. Mexico Pharmacovigilance Outsourcing, by Type USD Million (2023-2028)
  • Table 313. Mexico Pharmacovigilance Outsourcing, by Application USD Million (2023-2028)
  • Table 314. Mexico Pharmacovigilance Outsourcing, by Services USD Million (2023-2028)
  • Table 315. Mexico Pharmacovigilance Outsourcing, by Service Providers USD Million (2023-2028)
  • Table 316. Mexico Pharmacovigilance Outsourcing, by Clinical Trial Phase USD Million (2023-2028)
  • Table 317. Pharmacovigilance Outsourcing: by Type(USD/Units)
  • Table 318. Research Programs/Design for This Report
  • Table 319. Key Data Information from Secondary Sources
  • Table 320. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmacovigilance Outsourcing: by Type USD Million (2017-2022)
  • Figure 5. Global Pharmacovigilance Outsourcing: by Application USD Million (2017-2022)
  • Figure 6. Global Pharmacovigilance Outsourcing: by Services USD Million (2017-2022)
  • Figure 7. Global Pharmacovigilance Outsourcing: by Clinical Trial Phase USD Million (2017-2022)
  • Figure 8. South America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 9. Asia Pacific Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 10. Europe Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 11. MEA Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 12. North America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 13. Global Pharmacovigilance Outsourcing: by Type USD/Units (2017-2022)
  • Figure 14. Global Pharmacovigilance Outsourcing share by Players 2022 (%)
  • Figure 15. Global Pharmacovigilance Outsourcing share by Players (Top 3) 2022(%)
  • Figure 16. Global Pharmacovigilance Outsourcing share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Accenture plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Accenture plc (Ireland) Revenue: by Geography 2022
  • Figure 20. Clinquest Group B.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 21. Clinquest Group B.V (Netherlands) Revenue: by Geography 2022
  • Figure 22. Cognizant (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cognizant (United States) Revenue: by Geography 2022
  • Figure 24. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 25. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2022
  • Figure 26. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 27. IBM (United States) Revenue: by Geography 2022
  • Figure 28. ArisGlobal LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. ArisGlobal LLC (United States) Revenue: by Geography 2022
  • Figure 30. ITClinical (Portugal) Revenue, Net Income and Gross profit
  • Figure 31. ITClinical (Portugal) Revenue: by Geography 2022
  • Figure 32. Foresight Group International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Foresight Group International AG (Switzerland) Revenue: by Geography 2022
  • Figure 34. Take Solutions Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 35. Take Solutions Ltd. (India) Revenue: by Geography 2022
  • Figure 36. Global Pharmacovigilance Outsourcing: by Type USD Million (2023-2028)
  • Figure 37. Global Pharmacovigilance Outsourcing: by Application USD Million (2023-2028)
  • Figure 38. Global Pharmacovigilance Outsourcing: by Services USD Million (2023-2028)
  • Figure 39. Global Pharmacovigilance Outsourcing: by Clinical Trial Phase USD Million (2023-2028)
  • Figure 40. South America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 41. Asia Pacific Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 42. Europe Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 43. MEA Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 44. North America Pharmacovigilance Outsourcing Share (%), by Country
  • Figure 45. Global Pharmacovigilance Outsourcing: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Accenture plc (Ireland)
  • Clinquest Group B.V (Netherlands)
  • Cognizant (United States)
  • Laboratory Corporation of America Holdings (United States)
  • IBM (United States)
  • ArisGlobal LLC (United States)
  • ITClinical (Portugal)
  • Foresight Group International AG (Switzerland)
  • Take Solutions Ltd. (India)
Additional players considered in the study are as follows:
Bioclinica (United States) , Parexel International (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 212 Pages 95 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmacovigilance Outsourcing Market Quantitative research analysis
Global Pharmacovigilance Outsourcing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

detection,, assessment,, understanding, prevention of adverse effects and medicine/vaccine related are major end use applications of Pharmacovigilance Outsourcing market.
Top performing companies in the Global Pharmacovigilance Outsourcing market are Accenture plc (Ireland), Clinquest Group B.V (Netherlands), Cognizant (United States), Laboratory Corporation of America Holdings (United States), IBM (United States), ArisGlobal LLC (United States), ITClinical (Portugal), Foresight Group International AG (Switzerland) and Take Solutions Ltd. (India), to name a few.
The Concentration Rate of Global Pharmacovigilance Outsourcing market is highlighted using HHI Index.
"Increasing the Emphasis of Players in the Healthcare Sector Regarding the Treatment of Disease" is seen as one of major influencing trends for Pharmacovigilance Outsourcing Market during projected period 2022-2028.
The Pharmacovigilance Outsourcing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Pharmacovigilance Outsourcing Market Report?

Have a Query? Click Here

Other Related Reports

Stream Analytics Software Comprehensive Study by Application (Network Optimization and Management, Fraud Detection, Location Processing, Others), Organisation Size (SMEs, Large Enterprise), Deployme...
$ 3650
Big Data in Oil and Gas Sector Comprehensive Study by Type (Services, Software), Application (Upstream, Midstream, Downstream), End User Industry (Oil Industry, Gas Industry) Players and Region - Glo...
$ 3750
Data Science and Machine Learning Platforms Comprehensive Study by Type (Open-Source Platforms, Cloud-Based Platforms, Integrated Development Environments (IDEs)), Application (Python-based Platforms...
$ 3750
Data Entry Service Comprehensive Study by Type (Online Data Entry, Offline Data Entry), Application (E-commerce and Retail, Healthcare, Finance and Accounting), Industry Verticals (BFSI, IT and Telec...
$ 3750
Pet Foster Care Management Software Comprehensive Study by Organization Size (Small & Medium Enterprises (SMEs), Large Enterprises), Deployment (Cloud-Based, On-Premise), Pet Type (Cat, Dog, Others),...
$ 3450
Healthcare Analytics Outsourcing Comprehensive Study by End users (Healthcare Payers, Healthcare Providers), Deployment (On premise, Cloud), Service (Healthcare predictive analytics, Business intelli...
$ 3650